BOGLE INVESTMENT MANAGEMENT L P /DE/ - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 120 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$517,000
-19.0%
20,619
-37.9%
0.04%
-20.5%
Q1 2017$638,000
+123.9%
33,183
+51.3%
0.04%
+109.5%
Q3 2016$285,00021,9370.02%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders